High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents.

Ahmed Yahia ElmowafyHanzada Mohamed El MaghrabiMohamed Elsayed MashalyKhaled Farouk EldahshanLionel RostaingMohamed Adel Bakr

Published in: International urology and nephrology (2019)

Treatment of HCV among stage 2, 3a, and 3b patients was achieved safely with a sofosbuvir-based regimen. We recommend that stage-4 patients wait until starting hemodialysis or transplantation.

Keyphrases

hepatitis c virus
end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
ejection fraction
prognostic factors
patient reported outcomes
cell therapy
patient reported